Tadalafil Tablets Recalled Due to Incorrect Product Formulation
Sun Pharmaceutical is recalling Tadalafil Tablets USP 20 mg due to use of an incorrect grade of Crospovidone during manufacturing. The recall affects 36,786 bottles distributed to one distributor.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing defect (incorrect grade of excipient). No hospitalizations, illnesses, or injuries are reported in the source text, and the hazard is a formulation issue rather than contamination or high-risk pathogen. The classification meets the threshold for Moderate severity.
Plain-English summary
Sun Pharmaceutical Industries Inc is recalling Tadalafil Tablets, USP 20 mg, 30-count bottles because an incorrect grade of Crospovidone was used during manufacturing. The affected product was manufactured for Northstar Rx LLC in Memphis, Tennessee.
The recall involves 36,786 bottles of product with Lot Numbers DNC0814A and DNC0815A, with an expiration date of 04/2023. The product was distributed to one distributor who may have further distributed the product nationwide.
Consumers who have this medication should contact their healthcare provider or pharmacist for guidance. The product is identified by NDC # 16714-077-01.
The recalled product
- Product
- TADALAFIL (TADALAFIL)
- Brand
- TADALAFIL
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Hazard
- incorrect-formulation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # DNC0814A
- DNC0815A
- Exp. Date 04/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TADALAFIL
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-05-03
- ModerateTadalafil Tablets 20 mg recalled due to manufacturing deviations
FDA (Drugs) · 2023-05-03
- ModeratePrescription Tadalafil tablets recalled for manufacturing process deviations
FDA (Drugs) · 2023-04-12
- HighFDA Recalls Tadalafil Tablets Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
- ModerateTadalafil tablets recalled due to manufacturing process deviations
FDA (Drugs) · 2023-03-08
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22